ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,459, issued on Dec. 30.
"Inhibitors of NLRP3 inflammasome" was invented by George Hartman (Lansdale, Pa.), Yan Wang (Richmond, Calif.), Paul Humphries (Richmond, Calif.), Rusty Montgomery (Richmond, Calif.), Matthias Geyer (Bonn, Germany), Kevin Wilhelmsen (Richmond, Calif.) and Shijun Yan (Richmond, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds that act as inhibitors of NLRP3 inflammasomes; pharmaceutical compositions comprising the compounds; and methods of treating cancer and disorders associated with inflammation and inflammaging."
The patent was filed on March 25, 2025, under Application No. ...